Next-Generation Non-Contact Eye Examination System
Legal Citation
Summary of the Inventive Concept
A futuristic eye examination system utilizing AI, machine learning, and advanced optics to provide personalized vision care and treatment plans, revolutionizing the field of ophthalmology.
Background and Problem Solved
The original patent addressed the need for convenient and cost-effective eye examinations, but it had limitations in terms of accuracy, portability, and personalized treatment. The new inventive concept overcomes these limitations by integrating AI, machine learning, and advanced optics to provide real-time analysis, personalized recommendations, and customized treatment plans.
Detailed Description of the Inventive Concept
The next-generation eye examination system consists of a portable housing with a retractable aperture, a high-resolution camera, and a micro-electromechanical systems (MEMS) mirror for precise optical alignment. The system utilizes artificial intelligence for real-time analysis and personalized recommendations, and incorporates a machine learning algorithm to analyze eye data and predict potential vision problems. The system also includes a wearable device with an embedded camera and micro-sensors, a cloud-based data analysis platform, and a virtual reality interface for immersive vision therapy.
Novelty and Inventive Step
The new claims introduce the use of AI, machine learning, and advanced optics to provide personalized vision care and treatment plans, which is a significant departure from the original patent's focus on non-contact eye examination. The integration of these technologies enables real-time analysis, precise optical alignment, and customized treatment plans, making the new inventive concept novel and non-obvious.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept could include the use of different AI algorithms, varying types of sensors, or alternative virtual reality interfaces. The system could also be adapted for use in different settings, such as clinics, hospitals, or even homes.
Potential Commercial Applications and Market
The next-generation eye examination system has significant commercial potential in the ophthalmology industry, with potential applications in clinics, hospitals, and private practices. The system's ability to provide personalized vision care and treatment plans could also lead to partnerships with insurance companies and vision correction providers.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61B3/113 |
| A | A61 | A61B3/0008 |
| A | A61 | A61B3/0025 |
| A | A61 | A61B3/0041 |
| A | A61 | A61B3/102 |
| A | A61 | A61B3/103 |
| A | A61 | A61B3/12 |
| A | A61 | A61B3/135 |
| A | A61 | A61B3/16 |
| G | G16 | G16H40/67 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Ophthalmological diagnostic technologies, specifically non-contact eye examination systems involving optical measurement, imaging, and data analysis techniques
Person of Ordinary Skill (PHOSITA) Profile
A biomedical engineer or optical systems specialist with expertise in medical imaging, sensor technologies, machine learning applications in diagnostic systems, and advanced optical measurement techniques
Obviousness Rationale
A person skilled in the art would recognize that integrating artificial intelligence and machine learning into non-contact eye examination systems represents a predictable technological evolution given the existing optical tracking and measurement capabilities disclosed in the source patent. The fundamental non-contact examination framework provides a natural foundation for advanced data analysis and personalized diagnostic approaches. The technical elements required for such an enhancement are readily available and would be considered an obvious combination of known techniques in medical diagnostic technologies.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,259 |
|---|---|
| Title | Apparatus and method for automated non-contact eye examination |
| Assignee(s) | Scintellite, LLC |